Compounds of Formula (1.0.0): ##STR1## are described wherein A is for example aryl, heteroaryl or heterocyclyl, Y is preferably --C(.dbd.O)--; B is independently selected from a group of moieties, the most preferred of which are those of partial Formulas (1.1.2) and (1.1.6): ##STR2## and E is a single bond; oxygen; 1,1-cyclopropyl; C(CH.sub.3).sub.2 ; CF.sub.2 ; or a bridging moiety of partial Formula (1.9.0): ##STR3## where R.sup.1.sub.a is hydrogen when R.sup.1 has the meaning of a mono-valent substituent; and R.sup.1.sub.a is a single bond when R.sup.1 has the meaning of a di-valent substituent. Said compounds are useful in methods of treating or preventing an inflammatory, autoimmune or respiratory diseases by inhibiting cell adhesion and consequent or associated pathogenic processes subsequently mediated by VLA-4.

 
Web www.patentalert.com

< (none)

< Benzothiepin derivatives, process for the preparation of the same and uses thereof

> Liposome-entrapped topoisomerase inhibitors

> (none)

~ 00029